Latest debt-to-equity ratio
BridgeBio Oncology Therapeutics Debt-to-equity ratio
Direct answer
BridgeBio Oncology Therapeutics's debt-to-equity ratio is 0.78%.
The verified market snapshot reports 0.78%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 24, 2026.
Get free BridgeBio Oncology Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 0.78%
Explore related company data
View BridgeBio Oncology Therapeutics's market capitalizationView BridgeBio Oncology Therapeutics's price-to-book ratioView BridgeBio Oncology Therapeutics's return on equityView BridgeBio Oncology Therapeutics's 52-week price rangeView BridgeBio Oncology Therapeutics's profit marginView all BridgeBio Oncology Therapeutics key metricsReturn to BridgeBio Oncology Therapeutics profile